Nearly 900 people in New York City were advised to receive a third dose of Pfizer's COVID-19 vaccine after receiving doses that were left in a freezer for too long at a vaccination site in Times Square, the New York City Department of Health and Mental Hygiene confirmed to Becker's. 

CureVac issued a disappointing interim trial analysis June 16 for its COVID-19 vaccine, reporting its efficacy rate was just 47 percent.

The U.S. will invest more than $3 billion to develop antiviral drugs to treat COVID-19, HHS said June 17. 

Hospitals are taking a cautious approach to rolling out aducanumab, Biogen's Alzheimer's drug sold under the brand name Aduhelm.

A Care New England hospital became the first to administer Biogen's newly approved Alzheimer's drug, Aduhelm, to a patient outside a clinical trial, CNBC reported June 16. 

The U.S. bought 200 million more doses of Moderna's COVID-19 vaccine, the drugmaker said June 16.

Express Scripts has implemented a new policy for reporting 340B claims, and the American Hospital Association is urging the pharmacy benefit manager to withdraw it, arguing it will create "substantial burden and cost" for the U.S. healthcare system. 

HHS proposed June 16 getting rid of a rule created by former President Donald Trump that would require federally qualified health centers to pass discounts on insulin and epinephrine directly to patients. 

The FDA has authorized another batch of Johnson & Johnson COVID-19 vaccines made at Emergent BioSolutions' Baltimore plant to be distributed for use, the agency said June 15. 

Regeneron's COVID-19 antibody cocktail, casirivimab and imdevimab, reduced the risk of death among hospitalized patients in a phase 3 trial, the drugmaker said June 16.

St. Louis-based Ascension opened its new pharmacy services center June 15 in Austin, Texas.

Shortages of essential drugs is a challenge hospitals have always faced, but the American Society of Health-System Pharmacists has forecast that trade restrictions, pandemics and climate change will only increase the potential for more shortages. 

AstraZeneca said June 15 that its COVID-19 antibody drug doesn't prevent symptomatic COVID-19 infection in people recently exposed to the virus. 

Mississippi Attorney General Lynn Fitch is suing some of the country's largest insulin makers and pharmacy benefit managers, accusing them of working together to artificially inflate diabetes drug prices for profit. 

Five updates on Johnson & Johnson's COVID-19 vaccine, as reported by Becker's Hospital Review since the beginning of June: 

Ten hospitals and health systems posted job listings seeking pharmacy leaders in the last week.

The people who participate in prescription drug trials in countries outside the U.S. often don't get access to the drug once it's approved by the FDA, according to a recent study published in JAMA Network Open. 

Pfizer and AstraZeneca's COVID-19 vaccines were both highly effective in preventing hospitalization due to the delta variant of the virus that causes COVID-19, according to a study published June 14 by Public Health England. 

GlaxoSmithKline added to its cancer portfolio June 14 by signing an agreement with iTeos Therapeutics to co-develop and co-commercialize its experimental monoclonal antibody treatment for cancer.

Novavax said June 14 its vaccine is 100 percent effective at protecting against moderate to severe COVID-19 and 90.4 percent effective overall.